Quality control of oncology clinical trials

Hematology/Oncology Clinics of North America

Volumn 14, Issue 4, 2000, Pages 953-971

  Meyerson, Laura J ^a   Wiens, Brian L ^a   LaVange, Lisa M ^a   Koutsoukos, Antonis D ^a  

^a IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

BREAST CANCER; CANCER RESEARCH; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; COLORECTAL CANCER; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; ONCOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; STATISTICAL ANALYSIS;

EID: 0033871572     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70321-X     Document Type: Article

References (32)

1. Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study
2. Proving the null hypothesis' in clinical trials
3. Quality control in multi-centre cancer clinical trials
4. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06
5. Design of forms for cancer clinical trials
6. Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography
7. Assessing clinical trials - Rash adventures
8. Policies for study monitoring and interim reporting results
9. Alternative designs: Sequential, multi-stage, decision theory and adaptive designs
10. Trials to assess equivalence: The importance of rigorous methods
11. Discrete sequential boundaries for clinical tirals
12. False positive rates in randomized phase II designs
13. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project
14. A multiple testing procedure for clinical trials
15. Elapsed treatment days - A critical item for radiotherapy quality control review in head and neck cancer trials: RTOG report
16. Group sequential methods in the design and analysis of clinical trials
17. Surrogate endpoints in clinical trials: Definition and operational criteria
18. Radiology's Achilles heel: Error in variation in the interpretation of the Roentgen image
19. A decade of progress in statistical methodology for clinical trials
20. Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute
21. Planning cancer clinical trials
22. Impact of initial quality review on study outcome in lung and head/neck cancer studies-review of the Radiation Therapy Oncology Group experience
23. Errors, misunderstandings and fraud
24. A framework for the quality assurance of clinical data